SAN FRANCISCO — As a prophylactic measure in patients labeled primary angle-closure suspects, laser peripheral iridotomy may be overused, a speaker said.
At the American Glaucoma Society annual meeting, David S. Friedman, MD, MPH, PhD, delivered 72-month findings of the Zhongshan Angle Closure Prevention (ZAP) study, which looked at Chinese patients with PACS bilaterally who underwent laser peripheral iridotomy in one eye with the contralateral eye remaining untreated. Results were published concurrently in The Lancet.
“We used a composite endpoint,” Friedman said. “We
Uncategorized